Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors - PubMed (original) (raw)
Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors
R Maggio et al. Proc Natl Acad Sci U S A. 1993.
Abstract
We have tested the hypothesis that guanine-nucleotide-binding-protein-coupled receptors may be able to interact with each other at a molecular level. To address this question, we have initially created two chimeric receptors, alpha 2/m3 and m3/alpha 2, in which the C-terminal receptor portions (containing transmembrane domains VI and VII) were exchanged between the alpha 2C-adrenergic and the m3 muscarinic receptor. Transfection of COS-7 cells with either of the two chimeric constructs alone did not result in any detectable binding activity for the muscarinic ligand N-[3H]methylscopolamine or the adrenergic ligand [3H]rauwolscine. However, cotransfection with alpha 2/m3 and m3/alpha 2 resulted in the appearance of specific binding sites (30-35 fmol/mg of membrane protein) for both radioligands. These sites displayed ligand binding properties similar to those of the two wild-type receptors. Furthermore, COS-7 cells cotransfected with alpha 2/m3 and m3/alpha 2 were able to mediate a pronounced stimulation of phosphatidylinositol hydrolysis upon stimulation with the muscarinic agonist carbachol (Emax approximately 40-50% of wild-type m3). A mutant m3 receptor (containing 16 amino acids of m2 receptor sequence at the N terminus of the third cytoplasmic loop) that was capable of binding muscarinic ligands but was virtually unable to stimulate phosphatidylinositol hydrolysis was also used in various cotransfection experiments. Coexpression of this chimeric receptor with other functionally impaired mutant muscarinic receptors (e.g., with an m3 receptor containing a Pro-->Ala point mutation in transmembrane region VII) resulted in a considerable stimulation of phosphatidylinositol breakdown after carbachol treatment (Emax approximately 40-50% of wild-type m3). Thus, these data suggest that guanine-nucleotide-binding-protein-coupled receptors can interact with each other at a molecular level. One may speculate that the formation of receptor dimers involving the intermolecular exchange of N- and C-terminal receptor domains (containing transmembrane domains I-V and VI and VII, respectively) may underlie this phenomenon.
Similar articles
- Functional role of the third cytoplasmic loop in muscarinic receptor dimerization.
Maggio R, Barbier P, Fornai F, Corsini GU. Maggio R, et al. J Biol Chem. 1996 Dec 6;271(49):31055-60. doi: 10.1074/jbc.271.49.31055. J Biol Chem. 1996. PMID: 8940100 - Functional role of proline and tryptophan residues highly conserved among G protein-coupled receptors studied by mutational analysis of the m3 muscarinic receptor.
Wess J, Nanavati S, Vogel Z, Maggio R. Wess J, et al. EMBO J. 1993 Jan;12(1):331-8. doi: 10.1002/j.1460-2075.1993.tb05661.x. EMBO J. 1993. PMID: 7679072 Free PMC article. - Functional role of a cytoplasmic aromatic amino acid in muscarinic receptor-mediated activation of phospholipase C.
Blüml K, Mutschler E, Wess J. Blüml K, et al. J Biol Chem. 1994 Apr 15;269(15):11537-41. J Biol Chem. 1994. PMID: 8157684 - Muscarinic acetylcholine receptors: structural basis of ligand binding and G protein coupling.
Wess J, Blin N, Mutschler E, Blüml K. Wess J, et al. Life Sci. 1995;56(11-12):915-22. doi: 10.1016/0024-3205(95)00028-5. Life Sci. 1995. PMID: 10188793 Review. - Structural basis of receptor/G protein coupling selectivity studied with muscarinic receptors as model systems.
Wess J, Liu J, Blin N, Yun J, Lerche C, Kostenis E. Wess J, et al. Life Sci. 1997;60(13-14):1007-14. doi: 10.1016/s0024-3205(97)00041-6. Life Sci. 1997. PMID: 9121341 Review.
Cited by
- CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells.
Singer II, Scott S, Kawka DW, Chin J, Daugherty BL, DeMartino JA, DiSalvo J, Gould SL, Lineberger JE, Malkowitz L, Miller MD, Mitnaul L, Siciliano SJ, Staruch MJ, Williams HR, Zweerink HJ, Springer MS. Singer II, et al. J Virol. 2001 Apr;75(8):3779-90. doi: 10.1128/JVI.75.8.3779-3790.2001. J Virol. 2001. PMID: 11264367 Free PMC article. - GPCR oligomers in pharmacology and signaling.
González-Maeso J. González-Maeso J. Mol Brain. 2011 May 27;4(1):20. doi: 10.1186/1756-6606-4-20. Mol Brain. 2011. PMID: 21619615 Free PMC article. Review. - Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors.
Somvanshi RK, Kumar U. Somvanshi RK, et al. Pharmaceuticals (Basel). 2012 Apr 27;5(5):417-46. doi: 10.3390/ph5050417. Pharmaceuticals (Basel). 2012. PMID: 24281555 Free PMC article. - EP1- and FP-mediated cross-desensitization of the alpha (alpha) and beta (beta) isoforms of the human thromboxane A2 receptor.
Kelley-Hickie LP, Kinsella BT. Kelley-Hickie LP, et al. Br J Pharmacol. 2004 May;142(1):203-21. doi: 10.1038/sj.bjp.0705695. Epub 2004 Apr 20. Br J Pharmacol. 2004. PMID: 15100160 Free PMC article. - G protein activation by the leukotriene B4 receptor dimer. Evidence for an absence of trans-activation.
Damian M, Mary S, Martin A, Pin JP, Banères JL. Damian M, et al. J Biol Chem. 2008 Jul 25;283(30):21084-92. doi: 10.1074/jbc.M710419200. Epub 2008 May 19. J Biol Chem. 2008. PMID: 18490452 Free PMC article.
References
- FEBS Lett. 1993 Mar 15;319(1-2):195-200 - PubMed
- EMBO J. 1993 Jan;12(1):331-8 - PubMed
- Proc Natl Acad Sci U S A. 1983 Jan;80(1):156-9 - PubMed
- FEBS Lett. 1982 Dec 27;150(2):343-6 - PubMed
- Annu Rev Neurosci. 1987;10:195-236 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources